-
Mylan announces victory over Sanofi in Lantus patent claims
pharmaceutical-technology
December 17, 2018
Generic drug maker Mylan has announced that the US Patent and Trademark Appeal Board (PTAB) invalidated Sanofi’s patent infringement claims over insulin drug Lantus......
-
Mylan says Sanofi loses Lantus insulin patent claims
expressbpd
December 14, 2018
Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and paediatric patients with type 1 diabetes to control high blood sugar
-
US Patent Office Rules Sanofi's Formulation Patents on Multibillion-Dollar Lantus Invalid
americanpharmaceuticalreview
December 14, 2018
Mylan announced the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in its inter partes review (IPR) proceedings and .....
-
Sanofi may airlift flu shots into the U.K. in no-deal Brexit
fiercepharma
December 12, 2018
Several drugmakers are already stockpiling drugs in case of a no-deal Brexit.
-
Boehringer's France restructure will cull over 300 jobs
pharmafile
December 12, 2018
Boehringer Ingelheim is set to follow?in the recent steps of Sanofi?with the announcement of a cull of over 300 employees in France – around 10% of the company’s total workforce in the country.
-
Sanofi's controversial Dengvaxia picks up FDA priority review
fiercepharma
December 11, 2018
Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead...
-
Sanofi plots 670 layoffs in France as local tensions brew
fiercepharma
December 10, 2018
Sanofi may be on the up-and-up thanks to its vaccines unit and new anti-inflammatory star Dupixent, but the company still intends to shed more than 600 jobs in its home country over the next couple of years.
-
Sanofi announce cull of 670 French jobs
pharmafile
December 07, 2018
French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The company currently employs 25,000 employees across France.
-
Sanofi inks research deal to create digital asthma lab
fiercepharma
December 06, 2018
Sanofi plans to take asthma research where it has not gone before.
-
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
firstwordpharma
December 05, 2018
Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated i
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
